ATLANTA, Nov. 6, 2009 (GLOBE NEWSWIRE) -- Holzer Holzer & Fistel, LLC is investigating whether IMS Health, Inc.'s ("IMS" or the "Company") (NYSE:RX) directors complied with their fiduciary duties in approving the proposed buyout of IMS by TPG Capital and the CPP Investment Board. According to the Company's announcement of November 5, 2009, IMS shareholders will receive $22.00 for each IMS share they own. The investigation seeks to determine, among other things, whether the deal price is fair and adequate.
Current holders of IMS common stock with questions concerning their legal rights are encouraged to contact Holzer Holzer & Fistel, LLC and its attorneys Michael I. Fistel, Jr., Esq. or Marshall P. Dees, Esq. via email at mfistel@holzerlaw.com, or mdees@holzerlaw.com, or via toll-free telephone at (888) 508-6832.
Holzer Holzer & Fistel, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.